Bernstein raised the firm’s price target on Merck (MRK) to $100 from $95 and keeps a Market Perform rating on the shares. The firm notes Merck reported Q4 earnings with a slight beat on the top line and a larger beat on EPS. However, the greater debate focused around the much softer 2026 topline guide, Bernstein adds.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK: